2014/1/23 12:00
Condition: Hepatitis C
Interventions: Drug: Cocktail; Drug: DCV 3DAA FDC; Drug: BMS-791325
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified January 2014
2013/12/20 12:00
Conditions: Plasma Concentration; Pharmacokinetic Profile
Intervention: Drug: IntelliCap
Sponsor: AstraZeneca
Not yet recruiting - verified December 2013
2013/12/16 12:00
Conditions: Atrial Fibrillation; Atrial Flutter
Interventions: Drug: Metoprolol; Drug: Diltiazem
Sponsor: CAMC Health System
Not yet recruiting - verified December 2013
2013/12/10 12:00
Condition: Heart Failure
Interventions: Drug: Extended-Release Carvedilol Sulfate; Drug: Sustained-release Metoprolol Succinate
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Recruiting - verified December 2013
2013/11/12 12:00
Condition: Coronary Artery Disease
Intervention: Other: Coronary MR Angiography (CMRA)
Sponsor: Cedars-Sinai Medical Center
Recruiting - verified November 2013
2013/10/27 12:00
Conditions: Hypertension; Mild Cognitive Impairment
Interventions: Drug: Candesartan; Drug: Lisinopril
Sponsors: University of Southern California; Ihab Hajjar; National Institute on Aging (NIA)
Not yet recruiting - verified November 2013
2013/10/23 12:00
Conditions: Atrial Fibrillation; Atrial Flutter
Interventions: Drug: bucindolol hydrochloride; Drug: metoprolol succinate
Sponsors: ARCA Biopharma, Inc.; Medtronic
Not yet recruiting - verified November 2013
2013/10/22 12:00
Condition: Hypertension
Interventions: Drug: Extended-Release Carvedilol Sulfate; Drug: Sustained-release Metoprolol Succinate
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Recruiting - verified October 2013
2013/9/21 12:00
Condition: Patients With Coronary Artery Disease Scheduled for by Pass Surgery
Interventions: Drug: Amiodarone tab 200 mg x 2; Drug: rosuvastatin 10 mg tab x1; Drug: beta blockers Bisoprolol 1.25-2.5-5 mg. x 1, or Nebivolol 1.25-2.5-5 mg. x 1, or Metoprolol 25-50-100 mg. x 2
Sponsors: Heart Center BH Tuzla; Heart Center BH Tuzla
Not yet recruiting - verified September 2013
2013/7/15 12:00
Condition: Healthy
Interventions: Drug: Metoprolol tartrate immediate-release (metoprolol IR); Drug: JNJ-54452840; Drug: Placebo
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Not yet recruiting - verified July 2013
2013/7/8 12:00
Conditions: Acute Coronary Syndrome; Arterial Hypertension
Interventions: Procedure: Renal denervation; Drug: Metoprolol; Drug: Lisinopril
Sponsors: Meshalkin Research Institute of Pathology of Circulation; Meshalkin Research Institute of Pathology of Circulation
Recruiting - verified July 2013
2013/6/19 12:00
Condition: Fasting
Interventions: Drug: Metoprolol Succinate ER Tablets 50 mg; Drug: 'TOPROL-XL®' ER Tablets 50 mg
Sponsors: IPCA Laboratories Ltd.; IPCA Laboratories Ltd.
Completed - verified June 2013
2013/6/19 12:00
Condition: Fasting
Interventions: Drug: Metoprolol Succinate ER Tablet 200 mg; Drug: 'TOPROL-XL®' ER Tablets 200 mg
Sponsors: IPCA Laboratories Ltd.; IPCA Laboratories Ltd.
Completed - verified June 2013
2013/6/19 12:00
Condition: Fed
Interventions: Drug: Metoprolol Succinate ER Tablet 200 mg; Drug: 'TOPROL-XL®' ER Tablets 200 mg
Sponsors: IPCA Laboratories Ltd.; IPCA Laboratories Ltd.
Completed - verified June 2013
2013/5/18 12:00
Condition: B Thalassemia
Interventions: Drug: metoprolol; Drug: placebo
Sponsors: Shiraz University of Medical Sciences; Shiraz University of Medical Sciences
Completed - verified May 2013
2013/4/25 12:00
Conditions: Drug Biotransformation; Membrane Transport
Interventions: Drug: Codeine; Drug: Midazolam; Drug: Pravastatin; Drug: Torsemide; Drug: Talinolol; Drug: Caffeine; Drug: Metoprolol
Sponsors: Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH; Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
Recruiting - verified April 2013
2013/4/12 12:00
Conditions: Osteoarthritis; Cardiovascular Disease
Interventions: Drug: Metoprolol; Drug: Lisinopril; Drug: Atorvastatin; Behavioral: Lifestyle counseling
Sponsors: New York University School of Medicine; New York University School of Medicine
Not yet recruiting - verified April 2013
2013/2/22 12:00
Condition: Idiopathic Dilated Cardiomyopathy
Interventions: Drug: Carvedilol; Drug: Metoprolol succinate; Drug: Metoprolol succinate + doxazosin
Sponsors: University of Colorado, Denver; University of Colorado, Denver; National Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKline; AstraZeneca
Completed - verified January 2013
2012/12/26 12:00
Condition: Hypertension
Interventions: Drug: Metoprolol; Drug: Nebivolol
Sponsors: Forest Laboratories; Forest Laboratories
Active, not recruiting - verified December 2012
2012/12/19 12:00
Condition: Coronary Artery Disease
Intervention: Drug: Ivabradine and Metoprolol
Sponsors: Phramongkutklao College of Medicine and Hospital; Col. Suthee Panichkul; Phramongkutklao College of Medicine and Hospital
Not yet recruiting - verified December 2012